EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

ASSESSMENT OF EFFICACY OF PHOTOTHERAPY IN THE TREATMENT OF NEONATAL HYPERBILIRUBINEMIA

Shaik Sana Shinine*, Mulla Suraiya Tabassum, Dr. C. Venkatesh and Dr. B. Balaji Kumar

ABSTRACT

Background: Neonatal hyperbilirubinemia is the most commonly observed medical condition during the early days of birth. Phototherapy is a safe and effective treatment option for newborns with hyperbilirubinemia and the use of phototherapy may prevent the need for other treatment alternatives. Objective: The aim of our study was to assess the efficacy of phototherapy in the treatment of neonatal hyperbilirubinemia. Methodology: This was a prospective observational study done on 70 cases of newborns with hyperbilirubinemia and with an inclusion criteria of age < 1 week, Total serum bilirubin concentration ranges from 13-16 mg/dl, absence of other concomitant diseases and hyperbilirubinemia not requiring exchange transfusion. The subjects were exposed to phototherapy for about 3 days, and Total serum bilirubin concentration was measured before and after exposed to phototherapy. Findings: The total mean of Total serum bilirubin concentration before exposure to phototherapy was 14.2357 mg/dl ± 0.65, while mean after phototherapy exposure was 9.2742mg/dl ± 0.65. The mean TSB concentration was measured in relation to different categories gender, body weight, feeding pattern and Intravenous fluid intake. The significance difference was observed to the categories of body weight (0.01) and feeding pattern (0.03). Conclusion: This study was concluded that phototherapy was more effective in decreasing the elevated serum bilirubin concentration in neonates with hyperbilirubinemia & also concluded that the efficacy of phototherapy may differ in subjects with different categories of body weight and mode of feeding.

Keywords: Bilirubin, Neonatal hyperbilirubinemia, Phototherapy.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2025 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL 2025 issue has been successfully launched on APRIL 2025.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here